Great to hear from you Billy, your dulcet tones have been missed.
You will have of course seen that the business of NOR has been plugging along in much the same manner as always with the one notable exception. PO has formed a new private company, Avicena, which is providing WA Gov grant money to NOR via a software development contract. Somewhat confusingly PO trumpeted this contract in the latest 4C as "highlighting the value that third parties place in our technological capabilities".
You will also be pleased to know that according to PO "the Company continues to experience no material operational impact from COVID-19" but nonetheless "anticipates qualifying for ongoing government Covid-19 allowances in respect of some of its staff".
These new revenue streams seem to have made all the difference to the viability of the business over the last few months.
Other than that PO continues to confidently anticipate potentially material progress with developing key opportunities and reports still being afoot.
Hope you stick around!
- Forums
- ASX - By Stock
- NOR
- General Comments
General Comments, page-2339
-
-
- There are more pages in this discussion • 6,069 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $21.37M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.5¢ | $2.25K | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 68140 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 0.043 |
1 | 13888 | 0.041 |
3 | 450000 | 0.039 |
1 | 255000 | 0.038 |
2 | 1375000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 68140 | 1 |
0.047 | 142144 | 2 |
0.048 | 61184 | 1 |
0.050 | 590074 | 5 |
0.056 | 60000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online